The Woulgan Team is proud to announce our very own satellite symposium at the EWMA 2017 conference in Amsterdam.
EWMA has always been an important event for us and we hope to make even more health care professionals aware of the benefits of Woulgan at our symposium on May 3rd.
The symposium has the title: “Boost your treatment plans: Harness the power of macrophages in wound healing” and will be held from 3.30 to 4.30 pm on 3 May in room E102.
We are joined by Professor Dr. med. Matthias Augustin, who is the Director of the Institute for Health Services Research in Dermatology and Nursing (IVDP) at the University Medical Center Hamburg-Eppendorf, Germany, and one of the country’s leading opinion leaders within wound care.
He has an extensive publication portfolio with over 650 published papers and is one of the most cited authors in his field. Professor Dr. med. Augustin is also well renowned for his presentations and we’re glad that he will be joining our symposium to talk about the local impact of non-healing wounds.
Our symposium will furthermore be supported by Ron Legerstee, a consultant in wound healing and tissue repair, and lecturer from the Netherlands.
His focus lies on chronic wounds and he has published multiple important papers with other highly respected clinicians such as Keith Cutting and Professor Dr. med. Augustin. Legerstee is furthermore one of the invited speakers at the scientific program of EWMA and we are glad that he takes the time to talk about “The central role of macrophages in wound healing and their activation by Bioactive Beta-Glucan to restart healing” at our symposium.
Last but not least, Brenda King, nurse consultant in tissue viability from the UK, will speak about Bioactive Beta-Glucan in clinical practice.
King is the lead-author of the latest Woulgan paper published in the Journal of Wound Care after having led a focus group to evaluate the product. She is actively involved in clinical research and an experienced lecturer, and was bestowed the Wounds UK award 2007 for oedema management.
We hope that you will join us to learn more about the power of macrophages. If you’d like to pre-register your participation, you can do so by using the link below.
As always, we will also represent Woulgan at our booth in Hall 2, stall 2C30 (right next to catering). Feel free to come by for a chat and to learn more about this active therapy to re-start healing in stalled wounds.
Further information can also be found in the various e-posters that are on display at the conference, such as:
- “The use of a new, active treatment option to heal ten stalled wounds” by Brenda King
- “A clinical evaluation of a gel with beta-glucan in the management of non-infected diabetic foot ulcerations” by Donna Welch
- “Health economics of a gel with beta-glucan” and “Impact of a gel with beta-glucan in five wounds where healing was stalled” by Keith Cutting
- “Two case studies to demonstrate the use of a gel with beta-glucan for the treatment of stalled wounds” by Brenda King and Lynne Hepworth
- “A gel with beta-glucan promoted healing of two more than one year old wounds” by Kerstin Goldbach, Kathleen Tschaut and Alexandra Müller